Discontinued — last reported Q4 '25

Non-Current Assets

Software and Technology Licenses, Net

United Therapeutics Software and Technology Licenses, Net increased by 18.4% to $233.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $222.40M to $233.20M. Over 5 years (FY 2020 to FY 2025), Software and Technology Licenses, Net shows an upward trend with a 3.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryEfficiency
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase suggests ongoing investment in technology and digital capabilities, which can drive long-term operational efficiency.

Detailed definition

This represents the capitalized cost of acquired software and technology licenses, net of accumulated amortization. It r...

Peer comparison

Increasingly important across the restaurant sector as companies invest in mobile apps, kiosks, and data analytics.

Metric ID: software_technology_licenses_net

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$177.00M$109.00M$108.20M$113.30M$105.80M$114.80M$114.30M$124.50M$135.30M$141.70M$151.80M$169.10M$167.90M$183.60M$222.10M$222.40M$233.30M$262.60M$196.90M$233.20M
QoQ Change-38.4%-0.7%+4.7%-6.6%+8.5%-0.4%+8.9%+8.7%+4.7%+7.1%+11.4%-0.7%+9.4%+21.0%+0.1%+4.9%+12.6%-25.0%+18.4%
YoY Change-40.2%+5.3%+5.6%+9.9%+27.9%+23.4%+32.8%+35.8%+24.1%+29.6%+46.3%+31.5%+39.0%+43.0%-11.3%+4.9%
Range$105.80M$262.60M
CAGR+6.0%
Avg YoY Growth+19.2%
Median YoY Growth+26.0%

Frequently Asked Questions

What is United Therapeutics's software and technology licenses, net?
United Therapeutics (UTHR) reported software and technology licenses, net of $233.20M in Q1 2026.
How has United Therapeutics's software and technology licenses, net changed year-over-year?
United Therapeutics's software and technology licenses, net increased by 4.9% year-over-year, from $222.40M to $233.20M.
What is the long-term trend for United Therapeutics's software and technology licenses, net?
Over 5 years (2020 to 2025), United Therapeutics's software and technology licenses, net has grown at a 3.0% compound annual growth rate (CAGR), from $169.90M to $196.90M.
What does software and technology licenses, net mean?
The net book value of the company's software and technology licenses.